-
The Dana-Farber Campaign
Dana-Farber has played a critical role in the development of more than half of all cancer drugs approved by the FDA in the past 5 years.
-
$10 million gift brings rare cancers to the fore
The Linde Family Foundation has made a transformative $10 million gift to Dana-Farber to launch the Center for Therapeutic Discovery, which will develop novel therapies for patients with rare and hard-to-treat cancers.
-
The Dana-Farber Campaign
Establishing an endowment is a powerful way to support The Dana-Farber Campaign.
-
Expect Miracles Foundation raises record $1.25 million
A dedicated supporter of Dana-Farber Cancer Institute for more than 28 years, Expect Miracles Foundation marked a record-breaking year in 2022 by raising $1.25 million in support of the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber.
-
Massachusetts Life Sciences Center grants $2.8 million to establish new center and accelerate drug development
The Massachusetts Life Sciences Center (MLSC) has awarded Dana-Farber $2,811,397 to establish a Center for Emergent Drug Targets (CEDT), which will provide a collaborative environment to streamline and accelerate the earliest stages of drug discovery.
-
Couple commits $2 million to fund groundbreaking clinical trials
In 2017, a mammogram revealed that Langley Perer had ductal carcinoma in situ (DCIS), the very earliest, and highly treatable, stage of breast cancer.
-
Feenys invest in new treatments for advanced prostate cancer
In his 12 years as a prostate cancer patient, Chuck Feeny has learned quite a lot about the disease and how to navigate it. He takes each day in stride, every setback, every bit of good news and bad.